Parkinson Disease (PD)
![Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): [RETIRED]Report of the Quality Standards Subcommittee of the American Academy of Neurology](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw==)
Practice Parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): [RETIRED]Report of the Quality Standards Subcommittee of the American Academy of Neurology
... with Parkinson disease (PD) with dementia, depression, and psychosis based on these questions: 1) What tools are effective to screen for depression, psychosis, and dementia in PD? 2) What are ...
8
A loss of Pdxk model of Parkinson disease in Drosophila can be suppressed by Buffy
... to Parkinson disease (PD) gene led us to study the inhibition of this gene in the Dopa decarboxylase (Ddc)-expressing neurons of the well-studied model organism Drosophila ...to PD, that ...
9
Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles
... with Parkinson disease (PD) or Parkinson disease dementia (PDD) by assaying plasma α‑synuclein because the concentrations of circulating α‑synuclein in the blood are almost the same as ...
8
Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2
... early-onset PD, early dystonia, a history of seizures, and neurodevelopmental disorders such as schizophrenia or intellectual ...with PD later than antipsychotic-naive patients, despite the fact that few ...
10
Practice Parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review)Report of the Quality Standards Subcommittee of the American Academy of Neurology
... of Parkinson disease (PD) relating to neuroprotective strategies and alternative treatments, and to make evidence-based treatment ...with PD, are there any therapies that can slow ...
8
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls
... EU, Parkinson Fonds Deutschland, Deutsche Parkinson Vereinigung, MJFF, and Stif- terverband für die deutsche Wissenschaft; and has scientific collaborations with Roche, Bristol Myers Squibb, Ely Lilly, ...
13
Outcome of subthalamic nucleus deep brain stimulation on long-term motor function of patients with advanced Parkinson disease
... clinical data on long-term effectiveness of STN DBS on motor symptoms of PD patients, this study aimed to assess UPDRS score in PD patients who underwent STN DBS 6 years after their surgery. In addition we ...
5
Approach to diagnosis of Parkinson disease.
... to PD dementia, DLB is a relatively common cause of ...with PD usually develop dementia only after years with the disease and with severe motor ...
7
A Computerized Cognitive behavioral therapy Randomized, Controlled, pilot trial for insomnia in Parkinson Disease (ACCORD-PD)
... medications, punding, as well as primary sleep disorders [31, 32]. We performed the first randomized control trial to compare the effectiveness of web-based CBT-I compared to standard recommendations for insomnia in the ...
7
Carotid dissection causing occipital lobe infarction
... cardiovascular disease and is reported to be an independent risk factor for Alzheimer disease (AD) and cognitive ...and Parkinson disease ...
8
Cerebellar infarction after gamma knife radiosurgery of a vestibular schwannoma
... Parkinson disease (PD), multiple system atrophy (MSA), and progressive supranuclear palsy (PSP) are degenerative disorders of the CNS that share several common features, especially early in their ...
9
Detection of Parkinson'S Disease by Speech Analysis
... with Parkinson disease (PD) have speech and voice disorders at some time in the course of their ...with PD. In addition, people with PD may not be aware that they are getting softer in ...
5
Clinical Reasoning: A 56-year-old man with cognitive impairment and difficulty tying his necktie
... idiopathic Parkinson disease (PD) with PD-associated dementia, DLB, progressive supra- nuclear palsy (PSP), corticobasal degeneration (CBD), and multiple system atrophy ...in ...
8
Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson’s disease
... in PD and health ...Parkinson's Disease, Lewy Body Parkinson Disease, Primary Parkinsonism, Parkinsonism, Primary Parkinson Disease, Paralysis Agitans” and “REM Behavior ...
6
Clinical Reasoning: A 75-year-old man with parkinsonism, mood depression, and weight loss
... of Parkinson disease (PD) or an atypical parkin- sonism, including multiple system atrophy type P (MSA-P), progressive supranuclear palsy, basal ganglia calcification syndrome, or Perry ...
5
Parkinson’s Disease-A Case Study
... Parkinson Disease (PD) is a neurological disorder which interferes with the daily activity of ...This disease drops the level of dopamine in brain. Common symptoms of PD are slow ...
5
The Parkin’Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson’s disease
... The intervention consists of a combination of two soft- ware products. To give people insight into their cogni- tive profile and tailor the intervention towards an individuals’ weaknesses, the participants’ cognitive ...
11
Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease
... The research reported here was supported by the Department of Veteran Affairs, Veterans Health Administration, Health Services Research and Development Service (NRI 11 – 126). Dr. Karen Connor is a Health Scientist at ...
13
Neuronal degeneration and mitochondrial dysfunction
... HD, PD, and PSP — that have no obvious connection to primary mitochondrial bioenergetic ...neuron disease, but in a syndrome with unusual secondary ...“mitochondrial PD,” or “mitochondrial ALS”? ...
11
Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment
... This was likely due to the presence of prostate hyper- trophy in a significant number of male patients, that could have acted as a confounding factor. Indeed, corre- lations between SCOPA-U subscore and total and motor ...
5